Profiling of the Tox21 Chemical Collection for Mitochondrial Function to Identify Compounds that Acutely Decrease Mitochondrial Membrane Potential

Background: Mitochondrial dysfunction has been implicated in the pathogenesis of a variety of disorders including cancer, diabetes, and neurodegenerative and cardiovascular diseases. Understanding whether different environmental chemicals and druglike molecules impact mitochondrial function represents an initial step in predicting exposure-related toxicity and defining a possible role for such compounds in the onset of various diseases. Objectives: We sought to identify individual chemicals and general structural features associated with changes in mitochondrial membrane potential (MMP). Methods: We used a multiplexed [two end points in one screen; MMP and adenosine triphosphate (ATP) content] quantitative high throughput screening (qHTS) approach combined with informatics tools to screen the Tox21 library of 10,000 compounds (~ 8,300 unique chemicals) at 15 concentrations each in triplicate to identify chemicals and structural features that are associated with changes in MMP in HepG2 cells. Results: Approximately 11% of the compounds (913 unique compounds) decreased MMP after 1 hr of treatment without affecting cell viability (ATP content). In addition, 309 compounds decreased MMP over a concentration range that also produced measurable cytotoxicity [half maximal inhibitory concentration (IC50) in MMP assay/IC50 in viability assay ≤ 3; p < 0.05]. More than 11% of the structural clusters that constitute the Tox21 library (76 of 651 clusters) were significantly enriched for compounds that decreased the MMP. Conclusions: Our multiplexed qHTS approach allowed us to generate a robust and reliable data set to evaluate the ability of thousands of drugs and environmental compounds to decrease MMP. The use of structure-based clustering analysis allowed us to identify molecular features that are likely responsible for the observed activity. Citation: Attene-Ramos MS, Huang R, Michael S, Witt KL, Richard A, Tice RR, Simeonov A, Austin CP, Xia M. 2015. Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential. Environ Health Perspect 123:49–56; http://dx.doi.org/10.1289/ehp.1408642

[1]  Ruili Huang,et al.  The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.

[2]  C. Schmidt.  Unraveling Environmental Effects on Mitochondria , 2010, Environmental Health Perspectives.

[3]  S. Pieczenik,et al.  Mitochondrial dysfunction and molecular pathways of disease. , 2007, Experimental and molecular pathology.

[4]  B. Giardina,et al.  Anthracyclines and mitochondria. , 2012, Advances in experimental medicine and biology.

[5]  V. Betina,et al.  Uncoupling effect of fungal hydroxyanthraquinones on mitochondrial oxidative phosphorylation. , 1987, Chemico-biological interactions.

[6]  A. Hill,et al.  The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves , 1910 .

[7]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[8]  H. McBride,et al.  Mitochondria: More Than Just a Powerhouse , 2006, Current Biology.

[9]  Beate I Escher,et al.  Toward a class-independent quantitative structure--activity relationship model for uncouplers of oxidative phosphorylation. , 2008, Chemical research in toxicology.

[10]  P. Mitchell.  Coupling of Phosphorylation to Electron and Hydrogen Transfer by a Chemi-Osmotic type of Mechanism , 1961, Nature.

[11]  G. Lenaz.  Role of mitochondria in oxidative stress and ageing. , 1998, Biochimica et biophysica acta.

[12]  K. Utsumi,et al.  Tributyltin interacts with mitochondria and induces cytochrome c release. , 2001, The Biochemical journal.

[13]  Ruili Huang,et al.  Application of a homogenous membrane potential assay to assess mitochondrial function. , 2012, Physiological genomics.

[14]  P. Moldéus,et al.  Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in isolated rat hepatocytes. , 1998, Biochemical pharmacology.

[15]  S. Grant,et al.  Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms. , 2003, Molecular pharmacology.

[16]  A. Vercesi,et al.  Mitochondrial Effects of Triarylmethane Dyes , 1999, Journal of bioenergetics and biomembranes.

[17]  D. Marton,et al.  A proposal for a new mechanism of interaction of trialkyltin (TAT) compounds with mitochondria , 1997 .

[18]  Melvin E Andersen,et al.  Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[19]  Teuvo Kohonen,et al.  Self-organizing neural projections , 2006, Neural Networks.

[20]  Ruili Huang,et al.  Chemical Genomics Profiling of Environmental Chemical Modulation of Human Nuclear Receptors , 2011, Environmental health perspectives.

[21]  F. S. Sjostrand.  Electron Microscopy of Mitochondria and Cytoplasmic Double Membranes: Systems of Double Membranes in the Cytoplasm of Certain Tissue Cell , 1953, Nature.

[22]  C. Hoppel,et al.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. , 2001, Journal of molecular and cellular cardiology.

[23]  S. Nesci,et al.  Toxicity of organotin compounds: shared and unshared biochemical targets and mechanisms in animal cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  A. Lehninger,et al.  Transport of ornithine and citrulline across the mitochondrial membrane. , 1973, The Journal of biological chemistry.

[25]  S. Lin-Shiau,et al.  Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. , 1999, European journal of cancer.

[26]  L. Schwartz,et al.  Effects of troglitazone on HepG2 viability and mitochondrial function. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  R. Lill,et al.  The Essential Role of Mitochondria in the Biogenesis of Cellular Iron-Sulfur Proteins , 1999, Biological chemistry.

[28]  B. Street,et al.  Oxidative phosphorylation. Biochemical effects and properties of trialkyltins. , 1964, The Biochemical journal.

[29]  John J Lemasters,et al.  Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. , 2002, Antioxidants & redox signaling.

[30]  F. Sjöstrand,et al.  Electron Microscopy of Mitochondria and Cytoplasmic Double Membranes: Ultra-Structure of Rod-shaped Mitochondria , 1953, Nature.

[31]  Yvonne Will,et al.  Investigating mitochondrial dysfunction to increase drug safety in the pharmaceutical industry. , 2011, Current drug targets.

[32]  A. Saxena.  Organotin compounds: Toxicology and biomedicinal applications , 1987 .

[33]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Pál Pacher,et al.  Propagation of the apoptotic signal by mitochondrial waves , 2001, The EMBO journal.

[35]  Ruili Huang,et al.  Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screening. , 2013, Chemical research in toxicology.

[36]  B. O’Rourke,et al.  Role of mitochondrial dysfunction in cardiac glycoside toxicity. , 2010, Journal of molecular and cellular cardiology.

[37]  P. Weitzman,et al.  Organization of citric acid cycle enzymes into a multienzyme cluster , 1986, FEBS letters.

[38]  J. Bereiter-Hahn,et al.  Dynamics of mitochondria in living cells: Shape changes, dislocations, fusion, and fission of mitochondria , 1994, Microscopy research and technique.

[39]  Nigel Greene,et al.  The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  B. Hagihara,et al.  INHIBITORY ACTION OF TRIALKYLTIN COMPOUNDS ON OXIDATIVE PHOSPHORYLATION IN MITOCHONDRIA. , 1964, Journal of biochemistry.

[41]  P. Lin,et al.  Chronic exposure to bryostatin-1 increases the radiosensitivity of U937 leukaemia cells ectopically expressing Bcl-2 through a non-apoptotic mechanism. , 2000, International journal of radiation biology.

[42]  R. Kozłowski,et al.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.

[43]  H. Mantsch,et al.  Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line , 1999, Leukemia.

[44]  J. Lancaster,et al.  Steroidogenic electron transport in adrenal cortex mitochondria , 1982, Molecular and Cellular Biochemistry.

[45]  J. Dykens,et al.  Introduction to mitochondrial function and genomics , 1999 .

[46]  Ruili Huang,et al.  The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. , 2010, Drug discovery today.